SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER
PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R1to R5expres...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GRAY DAVID LAWRENCE FIRMAN XU WENJIAN BARTA NANCY SUE GLASE SHELLY ANN SIMONS LLOYD JEROME REICHARD GREGORY ADAM |
| description | PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R1to R5express each H, a 1-6C alkyl, an aryl, a 3-8C cycloalkyl, a 1-6C alkenyl, a 5-8C cycloalkenyl, a (CH2)n-3-8C cycloalkyl, a 1-6C alkoxy, an O-aryl or the like; * expresses a first chiral center; Ð expresses a second chiral center. COPYRIGHT: (C)2008,JPO&INPIT |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2008019267A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2008019267A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2008019267A3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w-EuxApax5pcbaTNlbuL4FSKxEm0UP8fFz_A6S1vnjUST6Jeo6KDlrirqfEBwVLbUQwOKmJQxlJ9OIPFoFw2EJCvFAXkJootOC_EDnmZzR7Dc0qrn4tsXaHaepPGd5-mcbinV_r0ly43pjDbY74_lLu_0hd9_C8w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER</title><source>esp@cenet</source><creator>GRAY DAVID LAWRENCE FIRMAN ; XU WENJIAN ; BARTA NANCY SUE ; GLASE SHELLY ANN ; SIMONS LLOYD JEROME ; REICHARD GREGORY ADAM</creator><creatorcontrib>GRAY DAVID LAWRENCE FIRMAN ; XU WENJIAN ; BARTA NANCY SUE ; GLASE SHELLY ANN ; SIMONS LLOYD JEROME ; REICHARD GREGORY ADAM</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R1to R5express each H, a 1-6C alkyl, an aryl, a 3-8C cycloalkyl, a 1-6C alkenyl, a 5-8C cycloalkenyl, a (CH2)n-3-8C cycloalkyl, a 1-6C alkoxy, an O-aryl or the like; * expresses a first chiral center; Ð expresses a second chiral center. COPYRIGHT: (C)2008,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080131&DB=EPODOC&CC=JP&NR=2008019267A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080131&DB=EPODOC&CC=JP&NR=2008019267A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRAY DAVID LAWRENCE FIRMAN</creatorcontrib><creatorcontrib>XU WENJIAN</creatorcontrib><creatorcontrib>BARTA NANCY SUE</creatorcontrib><creatorcontrib>GLASE SHELLY ANN</creatorcontrib><creatorcontrib>SIMONS LLOYD JEROME</creatorcontrib><creatorcontrib>REICHARD GREGORY ADAM</creatorcontrib><title>SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER</title><description>PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R1to R5express each H, a 1-6C alkyl, an aryl, a 3-8C cycloalkyl, a 1-6C alkenyl, a 5-8C cycloalkenyl, a (CH2)n-3-8C cycloalkyl, a 1-6C alkoxy, an O-aryl or the like; * expresses a first chiral center; Ð expresses a second chiral center. COPYRIGHT: (C)2008,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w-EuxApax5pcbaTNlbuL4FSKxEm0UP8fFz_A6S1vnjUST6Jeo6KDlrirqfEBwVLbUQwOKmJQxlJ9OIPFoFw2EJCvFAXkJootOC_EDnmZzR7Dc0qrn4tsXaHaepPGd5-mcbinV_r0ly43pjDbY74_lLu_0hd9_C8w</recordid><startdate>20080131</startdate><enddate>20080131</enddate><creator>GRAY DAVID LAWRENCE FIRMAN</creator><creator>XU WENJIAN</creator><creator>BARTA NANCY SUE</creator><creator>GLASE SHELLY ANN</creator><creator>SIMONS LLOYD JEROME</creator><creator>REICHARD GREGORY ADAM</creator><scope>EVB</scope></search><sort><creationdate>20080131</creationdate><title>SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER</title><author>GRAY DAVID LAWRENCE FIRMAN ; XU WENJIAN ; BARTA NANCY SUE ; GLASE SHELLY ANN ; SIMONS LLOYD JEROME ; REICHARD GREGORY ADAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2008019267A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GRAY DAVID LAWRENCE FIRMAN</creatorcontrib><creatorcontrib>XU WENJIAN</creatorcontrib><creatorcontrib>BARTA NANCY SUE</creatorcontrib><creatorcontrib>GLASE SHELLY ANN</creatorcontrib><creatorcontrib>SIMONS LLOYD JEROME</creatorcontrib><creatorcontrib>REICHARD GREGORY ADAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRAY DAVID LAWRENCE FIRMAN</au><au>XU WENJIAN</au><au>BARTA NANCY SUE</au><au>GLASE SHELLY ANN</au><au>SIMONS LLOYD JEROME</au><au>REICHARD GREGORY ADAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER</title><date>2008-01-31</date><risdate>2008</risdate><abstract>PROBLEM TO BE SOLVED: To provide a substituted morpholine compound for treating central nervous system disorders. SOLUTION: The compound expressed by formula (I) or its pharmaceutically permissible salts are provided. In the formula, A expresses O or S; X expresses a heterocyclic ring; R1to R5express each H, a 1-6C alkyl, an aryl, a 3-8C cycloalkyl, a 1-6C alkenyl, a 5-8C cycloalkenyl, a (CH2)n-3-8C cycloalkyl, a 1-6C alkoxy, an O-aryl or the like; * expresses a first chiral center; Ð expresses a second chiral center. COPYRIGHT: (C)2008,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JP2008019267A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED MORPHOLINE COMPOUND FOR TREATING CENTRAL NERVOUS SYSTEM DISORDER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T10%3A42%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRAY%20DAVID%20LAWRENCE%20FIRMAN&rft.date=2008-01-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2008019267A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |